Mozambique: Uptake of Injectable Prep Has Been High At Health Facilities

Maputo, the capital of Mozambique, has seen a high uptake of long-acting injectable PrEP against HIV at its 27 health facilities, according to Alice de Abreu, the Councilor for Health in Maputo Municipality. PrEP, a pre-exposure prophylaxis that uses anti-retrovirals, can reduce the risk of HIV infection by more than 99 percent.

De Abreu revealed that lenacapavir, the injectable form of PrEP, is being widely utilized, requiring patients to receive only two doses per year. This injectable PrEP has been chosen by many patients due to its convenience, reducing the need for frequent visits to health facilities while ensuring protection through just two doses annually.

The rollout of lenacapavir began in May, providing an additional HIV prevention method alongside existing options. The implementation strategy prioritizes vulnerable groups, including adolescents, young people, pregnant women, and key populations, although any eligible person can benefit from the method upon visiting a health facility.

During a working visit, parliamentarians from Germany and Luxembourg observed the operations of the chronic disease clinic, the Adolescent and Youth Health Services, and the prenatal clinic at the Xipamanine Health Center, noting the dedication of health professionals in providing care to various groups targeted by prevention efforts.

German Member of Parliament Johannes Wagner commended the care provided by health professionals in Maputo and called for further international cooperation to support Mozambique's health sector, especially considering the impacts of climate change and flooding.